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Introduction 
Parapneumonic empyema is defined as the presence of pus in the pleural cavity 
secondary to pneumonia. According to the World Health Organisation in 2006, 
pneumonia remained the key leading cause of death in children less than 5 years old. 
The estimated prevalence of childhood pneumonia in developed world was 
approximately 33 per 10000 and 14.5 per 10000 in children younger than 5 and from 
0 to 16 years old respectively [1]. Parapneumonic empyema had previously been a 
rare complication of childhood pneumonia which constituted less than 1% among 
those hospitalized for the disease [2]. Despite the ubiquitous uptake of pneumococcal 
vaccine leading to the bacteria’s consequential decline in the incidence of childhood 
pneumonia worldwide, the prevalence of parapneumonic empyema has been 
escalating recently [3-8]. The prognosis of parapneumonic empyema in children is 
generally good with less than 5% mortality rate [9] as compared to near 20% in adults 
[10]. Notwithstanding, its impact on family and hospital burden is still considerable.  
Being one of the most commonly encountered yet difficult to manage paediatric 
thoracic conditions, there are myriads of management strategies towards 
parapneumonic empyema advocated worldwide. These include both conservative and 
surgical management. Hospitalisation and high dose broad spectrum intravenous 
antibiotics are the first step of management employed in most centres. Therapeutic 
thoracocentesis can also be used for empyema drainage. However, the British 
Thoracic Society guidelines recommended a chest tube for cases in which the first 
thoracocentesis failed to adequately drain the effusion in order to avoid multiple 
attempts [7]. Hence, insertion of chest tube drainage remained the traditional and 
mainstay of management for majority of cases. Although high dose intravenous 
antibiotics and chest drain insertion may be adequate in some cases, chest tube 
drainage is frequently impaired by the presence of fibrin strands and loculation in 
complicated cases. For these patients, chemical debridement with fibrinolytic agents 
such as urokinase, streptokinase and tissue plasminogen activator has been proposed 
[11], but surgical decortication of empyema remains the last resort of management in 
refractory cases where these measures failed [12]. There are several non-randomised 
studies comparing patients who underwent thoracoscopic decortication versus 
thoracotomy and made credits on the thoracoscopic approach for its advantage of 
decreased postoperative pain, faster recovery, shorter hospital stay and less long term 
morbidity [11]. However few studies explored the effect of timing of decortication on 
the peri-operative outcome. Therefore this study was carried out to investigate the 




A retrospective analysis was conducted using our electronic patient database for 
patients with parapneumonic empyema treated at our tertiary referral centre between 
1999 and 2013. An approval from the ethics committee was sought before conducting 
the study. All patients with confirmed diagnosis were identified and their records were 
reviewed. No patient was excluded from the study. All patients received chest X-ray 
and computed tomography of thorax to confirm the diagnosis and to evaluate disease 
progression. All patients received intravenous antibiotics as soon as the diagnosis of 
pneumonia or empyema was made and chest drainage by means of chest drain or 
pigtail catheter insertion was given to patients subsequently for drainage. No 
fibrinolytic agent was used in any of the patients because its use in pleural cavity was not 
licensed in our locality. Indication for thoracoscopic decortication included 1) persistent 
fever >38.5 degree Celsius or increasing white cell count despite appropriate intravenous 
antibiotics and chest drainage for more than 72 hours or 2) loculated empyema on 
reassessment computed tomography of thorax. This protocol has been consistent during the 
whole study period and emergency operations were arranged once patients met the criteria. 
Selected patients were transferred to intensive care unit for post-operative monitoring 
following the procedure. All patients were continued with intravenous antibiotics 
post-operatively with regular chest physiotherapy. The demographics of patients 
including gender, age at presentation, maturity at birth, weight at birth, vaccination 
received and past medical history were collected. Their presenting symptoms, date of 
fever from symptoms onset, laboratory results including white cell counts, the timing 
of computed tomography received, the site and size of empyema, any presence of 
loculation, the duration and output of chest drain insertion were analysed. 
Peri-operative data such as timing of operation, total operative time and intraoperative 
blood loss were recorded. Medical records were reviewed for days of post-operative 
intubation, length of post-operative intensive care unit stay, presence of post-operative 
fever, complications, length of post-operative hospitalization and long term 
complications on follow-up. 
Thoracoscopic decortication was performed under general anaesthesia. Patient was 
placed in lateral decubitus position with the diseased side up. The ipsilateral arm was 
placed and fixed over patients’ head. Single lung ventilation was not necessary. 
Pneumothorax with insufflation of carbon dioxide at low flow (1 L/min) and low 
pressure (2-4 mmHg) was usually adequate for good exposure. Three 5mm ports were 
placed, one for the camera and two additional ports as working channels. The camera 
port was inserted in the third intercostal space at the mid-axillary line with open 
method. If a chest drain was inserted before the operation then the site was used for 
camera port placement. A 5 mm 30° telescope was then inserted to directly visualize 
the placement of the two working ports, which were inserted in the fourth intercostal 
space at the anterior and posterior axillary line respectively. Fibrinous and purulent 
material in the pleural cavity was suctioned. Loculations were broken down with 
forceps and pleura decorticated mechanically. Thoracic cavity was then irrigated after 
adequate debridement and decortication. Once expansion of lung is visualized and 
confirmed, a chest tube would be left in-situ post-operatively and connected to under 
water seal. Reassessment chest X-rays were done during the post-operative period for 
monitoring clinical progress.  
Patients were divided into 2 groups according to the duration from symptom onset to 
operation. The arbitrary cut-off point of 14 days to define early surgery was used because we 
postulated that patient can benefit more if surgery was performed during the initial exudative 
or fibrinopurulent phase of empyema. 
All data were statistically compared. Statistical analysis of data was performed using 
SPSS (version 17; SPSS, Chicago, IL). Continuous variables were analyzed using 
Student’s t test, ordinal variables were analyzed using Mann-Whitney U test and 
categorical variables were analyzed using chi-square test respectively. Data were 




A total of 37 patients were admitted for the diagnosis of empyema during the study 
period, with 9 patients being treated medically and 28 eventually required operative 
treatment. All the 9 patients treated successfully with conservative treatment 
responded well to antibiotics within 14 days. 12 males and 16 females received 
thoracoscopic decortication. The mean age of patients was 4.5 years old (range 12 
months to 14 years). The mean body weight at the time of operation was 20.0 kg 
(range 9.9 - 47.5kg). Right-sided empyema was involved in 15 patients. 6 patients had 
received pneumococcal vaccination prior to the onset of chest symptoms. All patients 
received thoracic computed tomography before operation to confirm the diagnosis. 
Intravenous antibiotics and chest drainage procedure were given to all patients once 
the diagnosis was made.  
Subgroup analysis for the 2 groups of patients was shown in Table 1. Patients who 
had operation within 2 weeks from symptom onset were assigned to group 1 (16 
patients) and those more than or equal to 2 weeks were assigned to group 2 (12 
patients). Both groups had similar demographics in terms of age, sex, body weight 
and laterality of lesion. 6 (37.5%) patients in group 1 had chest drain inserted before 
operation and 7 (58.3%) in group 2. The rest of the patients who did not receive chest 
drain insertion underwent pigtail catheter insertion for drainage. None of the patients 
in group 1 received chest drainage revision after its insertion but it was necessary in 5 
of the patients in group 2. 
Group 1 patients received thoracoscopic decortication at 9.5 days on average (range 
5-13 days) while those in group 2 had operation at 18.4 days (range 14-25 days). The 
mean operative time in group 1 was comparable to that of group 2 (80.3 vs 95.3 
minutes, p=0.3). Mean operative blood loss in group 1 and 2 were 46.9 and 106.3 ml 
respectively (p=0.06). One patient in group 1 required conversion to open 
thoracotomy due to severe adhesion, while 2 patients in group 2 were converted due 
to same reason. Another patient in group 2 was converted due to severe bleeding and 
unstable hemodynamics. 
3 patients in each group were kept intubated post-operatively but all of them were 
extubated the next day. The average intensive care unit stay for group 1 and 2 were 
3.6 (range 0-10 days) and 7.8 days (range 0-23 days) respectively (p=0.1). The mean 
time for patient to become afebrile in group 1 was 2.5 days (range 1-10 days) while 
that for group 2 was 7 days (range 2-20 days, p=0.04). Chest drains were removed 5.0 
days (range 3-9 days) and 8.9 days (range 2-31 days) after the operation for group 1 
and 2 respectively (p=0.11). The duration of intravenous antibiotics required after 
operation was 9.6 days (range 2-17 days) in group 1 and 15.8 days (range 4-28 days) 
in group 2. Patients in group 1 showed significant shorter post-operative hospital stay 
(mean 9.5 days, range 5-19 days) than group 2 (mean 20.4 days, range 5-42 days, 
p=0.003). The mean total hospitalization duration in group 1 was also significantly 
shorter than that of group 2 (mean 19.3 vs 38.8 days, p<0.001). Correlation study 
demonstrated a positive relationship between delay in operation and prolonged 
hospitalization (r=0.63, p=0.001). No major post-operative complication was 
encountered except for one patient requiring a second decortication for residual 
empyema. Summary of operative outcomes are shown in table 2. 
 
Discussion 
The best treatment approach for parapneumonic empyema has long been debated. 
Choices for treatment include conservative ways such as high dose intravenous 
antibiotics and chest tube drainage. In complicated cases which involve loculations, 
surgical intervention such as thoracoscopic or open decortication is beneficial and 
essential for drainage of empyema. The top priorities of treatment are to achieve 
clearance of infectious material in the pleural cavity and to attain re-expansion of the 
lungs. While empyema could lead to increased morbidity and mortality with its 
rapidly progressive course, it has been a question for surgeons on the optimal timing 
of decortication or surgical drainage.  
The development of parapneumonic empyema is generally divided into three stages. 
They are comprised of: Stage 1, which is an exudative phase characterized by a clear, 
thin, and sterile pleural effusion; Stage 2, which is a transitional or fibrinopurulent 
phase where the fluid becomes thick, infected, and purulent; and lastly Stage 3, which 
is an organizing or consolidative phase in which granulation tissue is formed and 
encases the lung [13]. Clinical and pathological stages of parapneumonic empyema 
pose great influence on choices as well as effect of different management strategies. 
For instance, during early stage where the effusion is of lower cellular content and 
better fluidity, thoracocentesis or chest tube insertion alone may be sufficient for 
achieving the treatment goals as mentioned above. However as the exudative phase is 
generally brief and often missed, most cases are admitted to the hospital during their 
fibrinopurulent phase in which fluid became denser and simple drainage may not be 
adequate for clearance of empyema [14]. 
Thoracoscopic decortication has been advocated to treat parapneumonic empyema for 
its benefits of less pain, more rapid recovery, lower postoperative morbidities, 
complications and mortalities. There are myriads of studies carried out to evaluate the 
role of thoracoscopic decortication in parapneumonic empyema. Shivachev et al 
recruited 87 children from 2004 to 2006 and proved that thoracoscopic decortication 
was effective in managing children with complicated parapneumonic effusion in the 
second (fibrino-purulent) stage, as well as by in the third (organizing) stage for some 
[15]. Shahin et al found that 62% of the patients with stage 3 empyema in their study 
underwent VATS decortication with a successful outcome. The postoperative length of 
hospital stay was shorter and the postoperative complications were less when 
compared with the open approach [13]. In a large retrospective study by Bishay et al 
in 2008 with 114 children with empyema, 91% had full resolution of their symptoms 
with thoracoscopic approach and demonstrated that if performed with expertise 
excellent results can be achieved in children with empyema [16]. In another major 
study by Luh et al with 234 patients, 86.3% of them achieved satisfactory results with 
thoracoscopic treatment [17]. Yamaguchi et al assessed complications and failures in 
151 children with empyema treated with thoracoscopic means and the quoted success 
rate was 82.6% [18]. The role of thoracoscopic decortication in the management of 
parapneumonic empyema has been compared with chest tube drainage alone or with 
the aid of fibrinolytics. Biligin et al concluded that thoracoscopic surgery is 
cost-effective and could shorten the hospitalization time with early discharge of 
patients from the hospital when compared to pure chest tube drainage [14]. They 
recommended that thoracoscopic surgery would be beneficial in well-equipped major 
centres and should be done early in the fibropurulent phase to allow early recovery 
and prevent further complications. In a study by Klena et al with 21 patients identified 
between 1994 and 1997, thoracoscopic decortication was found to be most likely 
successful within 1 week after the diagnosis of empyema [19]. The use of fibrinolytic 
agents had raised much attention in recent years [20]. There had been results from 
randomized trials suggesting a statistical significant shorter hospital stay by 2 days 
[21]. However its use has not gained universal acceptance due to contradicting results 
from large multi-centre retrospective studies which showed similar hospital stays and 
significant increase in failure rate [22, 23]. Reports of severe life threatening 
complication such as haemothorax and allergy also limited its popularity [24, 25]. 
Thus far only few studies in the literature have investigated the effect of timing of 
thoracoscopic decortication in childhood empyema. In a recent study reported by 
Chung et al [26] focusing on this issue in adult population, comparisons were made 
between patients operated within 2 weeks, 2 to 4 weeks and beyond 4 weeks from 
symptom onset. The operative time was significantly shorter in those operated early 
(100.93 vs 125 minutes) owing to the less severe adhesions and debris organization. It 
was in contrast to our results here, which showed the mean operative time was 
comparable between the two groups (80.3 vs 95.3 minutes, p=0.31). Nonetheless, we 
did notice a marked decrease in operative blood loss in group 1 (46.9ml) with a mean 
difference of 60ml from group 2 (106.3ml). It was probably due to the same reason of 
less severe adhesion in the early-operated group, though statistical significance was 
not reached (p=0.06) owing to the small sample size. In Chung’s study the duration of 
chest tube drainage, post-operative hospitalization and intensive care unit stay were 
all shorter in those operated less than 2 weeks, with all of them showing statistical 
significance except the last one. The results were similar in our study where chest 
tubes were removed 5 days after operation in group 1 compared to 8.9 days in group 2  
(p=0.11). In addition, the post-operative hospital stay (mean 9.5 vs 20.4 days, p=0.003) 
and total hospitalization duration (mean 19.3 vs 38.8 days, p<0.001) were 
significantly shorter in group 1.  
The reason behind the earlier recovery and discharge was partly due to the shorter 
febrile duration, which was 4.5 days shorter in group 1 (p=0.04). The better clearance 
of dense fibrinopurulent material in parapneumonic empyema by thoracoscopic 
means as compared to pure chest tube drainage is furthered affirmed with this finding. 
Earlier chest drain removal and shorter febrile period all added up to the faster 
cessation of intravenous antibiotics therapy, and subsequently translated into the 
speedy discharge and recovery. There was no major post-operative complication 
identified in our study except in one patient with recurrence and required second 
thoracoscopic decortication, who had a very delayed presentation.  
With the aforementioned results, timely thoracoscopic decortication of 
parapneumonic empyema was justified to promote earlier recovery of paediatric 
patients in concordance with previous studies. This could be explained by the fact that 
most cases are presented at stage 2 (fibrinopurulent) where chest tube drainage would 
not be sufficient in enhancing the clearance of empyema. Thus, the shorter the time it 
takes to performing thoracoscopic decortication, from symptom onset, the better the 
benefit of rapid recovery could be attained. We acknowledge that this study had 
limitations with its small sample, and as a result, some of the peri-operative outcomes 
did not reach statistical significance. Furthermore, the retrospective nature of the 
study might have limited its validity. 
In conclusion, we would recommend early thoracoscopic decortication in managing 
children with parapneumonic empyema. Large scale randomized study is essential for 
more robust data. 
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